HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
HOME
HK STOCK
ALL
Announcement
IPOs
Research
Market
Company
CHINA STOCK
ALL
Announcement
IPOs
Research
Market
Company
US STOCK
ALL
Financial Report
New Share
Market
Research
Company
RECOMMENDATIONS
ALL
World News
Hong Kong & MaCao
China News
General News
Search for topics & keywords
Search
LIVZON PHARMA (01513) spent approximately 8.5975 million Hong Kong dollars to repurchase 323,600 shares on November 20th.
20/11/2024
GMT Eight
LIVZON PHARMA (01513) announced that on November 20, 2024, it spent approximately HKD 8.5975 million to repurchase 32.36 thousand shares.
Due to the exercise of share options, GENSCRIPT BIO issued 1.922 million shares.
Huatai (06886): "23 Huatai F2" will pay interest on November 27th.
RECOMMEND
The subsidiary of Guangdong Zhongsheng Pharmaceutical (002317.SZ), Zhongsheng Ruichuang Innovative Medicine RAY1225 Injection, has achieved the expected goals in Phase II clinical trials for weight reduction.
9 min ago
Wuxi Lihu Corporation (300694.SZ): The relevant reports do not constitute undisclosed significant information that may have a significant impact on the company's stock trading price.
15 min ago
Dongjiang Environmental (00895) has completed the issuance of 500 million yuan of medium-term notes.
15 min ago
©️2013 - 2024 GMT EIGHT Holdings. All Rights Reserved.
Contact: contact@gmteight.com